Cargando…

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

Detalles Bibliográficos
Autores principales: Kim, JH, Kamasuta, C, Trichavaroj, R, Kaewkungwal, J, Chantakulkij, S, Ratto-Kim, S, Eamsila, C, Sukwit, S, Nitayaphan, S, Pitsuttihum, P, Michael, NL, Chiu, J, Rerks-Ngarm, S, de Souza, MS, Paris, RM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767552/
http://dx.doi.org/10.1186/1742-4690-6-S3-O30
_version_ 1782173320667463680
author Kim, JH
Kamasuta, C
Trichavaroj, R
Kaewkungwal, J
Chantakulkij, S
Ratto-Kim, S
Eamsila, C
Sukwit, S
Nitayaphan, S
Pitsuttihum, P
Michael, NL
Chiu, J
Rerks-Ngarm, S
de Souza, MS
Paris, RM
author_facet Kim, JH
Kamasuta, C
Trichavaroj, R
Kaewkungwal, J
Chantakulkij, S
Ratto-Kim, S
Eamsila, C
Sukwit, S
Nitayaphan, S
Pitsuttihum, P
Michael, NL
Chiu, J
Rerks-Ngarm, S
de Souza, MS
Paris, RM
author_sort Kim, JH
collection PubMed
description
format Text
id pubmed-2767552
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27675522009-10-28 OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial Kim, JH Kamasuta, C Trichavaroj, R Kaewkungwal, J Chantakulkij, S Ratto-Kim, S Eamsila, C Sukwit, S Nitayaphan, S Pitsuttihum, P Michael, NL Chiu, J Rerks-Ngarm, S de Souza, MS Paris, RM Retrovirology Oral Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767552/ http://dx.doi.org/10.1186/1742-4690-6-S3-O30 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Oral Presentation
Kim, JH
Kamasuta, C
Trichavaroj, R
Kaewkungwal, J
Chantakulkij, S
Ratto-Kim, S
Eamsila, C
Sukwit, S
Nitayaphan, S
Pitsuttihum, P
Michael, NL
Chiu, J
Rerks-Ngarm, S
de Souza, MS
Paris, RM
OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
title OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
title_full OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
title_fullStr OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
title_full_unstemmed OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
title_short OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
title_sort oa04-06 lb. post-infection cellular immune responses in recipients following alvac-hiv® + aidsvax® b/e prime-boost vaccination in the thai phase iii trial
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767552/
http://dx.doi.org/10.1186/1742-4690-6-S3-O30
work_keys_str_mv AT kimjh oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT kamasutac oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT trichavarojr oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT kaewkungwalj oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT chantakulkijs oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT rattokims oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT eamsilac oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT sukwits oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT nitayaphans oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT pitsuttihump oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT michaelnl oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT chiuj oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT rerksngarms oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT desouzams oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial
AT parisrm oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial